INTRALINE® ONE

Key Features:

• Biphasic Gel Technology: Combines cross-linked and non-cross-linked HA for enhanced elasticity and longevity.
• High HA Concentration: Contains 20 mg/ml of Hyaluronic Acid for smoother texture and increased skin hydration.
• Cross-Linking Method: Utilizes BDDE cross-linking to ensure gel integrity and improved results.
• Needle Size: Equipped with 27G needles for precision and minimal discomfort during injection.
• Packaging: Comes in a 1.0 ml syringe with two 27G needles, ideal for ease of application in various treatment areas.
• Long-Lasting Results: Effects typically last between 6–12 months, depending on individual factors such as skin type and lifestyle.

Indications:

• Facial Wrinkles and Folds: Targets fine to medium wrinkles, including those in the labial commissures, cupid’s bow, nasolabial folds, and marionette lines.
• Lip Enhancement: Ideal for lip augmentation and subtle lip definition, improving the contour and volume of the lips.
• Tear Troughs: Used to reduce the appearance of under-eye hollows and improve skin smoothness.
• Crow’s Feet: Effective for eye area treatments, particularly around the crow’s feet and fine lines.

Contraindications:

• Active Skin Infections: Not suitable for patients with active infections or inflammation in the treatment area.
• Pregnancy and Breastfeeding: Should not be used during pregnancy or breastfeeding due to lack of safety data.
• Allergies to Hyaluronic Acid: Not recommended for individuals with known allergies to Hyaluronic Acid or BDDE cross-linked compounds.

Side Effects:

• Common Reactions: Minor swelling, redness, or tenderness at the injection site are common and typically resolve within a few days.
• Uncommon Reactions: Rare side effects may include hematomas, granulomas, necrosis, or pigmentation. If these occur, medical attention should be sought immediately.

Ingredients:

• Hyaluronic Acid: The main ingredient, contributing to hydration and collagen production. Derived via bio-fermentation, this HA is non-animal derived, ensuring purity and biocompatibility.
• BDDE (Butanediol Diglycidyl Ether): The cross-linking agent used to improve gel consistency and extend the duration of the filler’s effects.

Packaging:

• Each syringe contains 1.0 ml of the gel.

Needle Size: Includes two 27G needles, optimized for precise injections in delicate areas like the lips and under-eye region.

Method of Use:

1. Preparation: The treatment area should be cleansed thoroughly before the procedure. Local anesthesia may be applied to ensure patient comfort.
2. Injection: Using a 27G needle, the practitioner will inject Intraline One into the mid dermis. The biphasic gel will help lift and smooth the skin, targeting wrinkles and volume loss.
3. Post-Treatment Care: After the procedure, patients should avoid touching the treated areas for 6 hours and refrain from sun exposure or strenuous activity for 2-3 days to ensure proper healing.